Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Switching the targeting pathways of a therapeutic antibody by nanodesign.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Switching the targeting pathways of a therapeutic antibody by nanodesign.
Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl. 2012 Feb 13; 51(7):1563-7.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Cell Line, Tumor
Cetuximab
Drug Design
Gold
Humans
Metal Nanoparticles
Models, Biological
Nanoconjugates
authors with profiles
Priyabrata Mukherjee
Resham Bhattacharya